Institutional Ownership
Revolution Medicines Inc
CUSIP 76155X100COMRVMDQ1 2026
13D / 13G Filings
61
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
14.1%
Max % of class reported
Institutional Holders
503
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
61 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Baker Bros. Advisors LP | 13G/A | 4.9% | 9.46M | SEC |
| 2 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | 3.6% | 6.99M | SEC |
| 3 | Feb 9, 2026 | Farallon Capital Partners, L.P. | 13G/A | 7.5% | 14.60M | SEC |
| 4 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 6.1% | 11.36M | SEC |
| 5 | Nov 5, 2025 | Fmr LLC | 13G | 5.0% | 9.40M | SEC |
| 6 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.7% | 10.59M | SEC |
| 7 | Aug 14, 2025 | Baker Bros. Advisors LP | 13G | 5.0% | 9.36M | SEC |
| 8 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 5.5% | 10.26M | SEC |
| 9 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 4.5% | 8.40M | SEC |
| 10 | May 15, 2025 | Farallon Capital Partners, L.P. | 13G/A | 7.9% | 13.26M | SEC |
51 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Revolution Medicines Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Farallon Capital Management LLC | 13.60M | $1.32B |
| 2 | Blackrock, Inc. | 11.21M | $1.09B |
| 3 | Janus Henderson Group PLC | 9.77M | $949.54M |
| 4 | Baker Bros. Advisors LP | 9.56M | $929.26M |
| 5 | Fmr LLC | 8.46M | $823.15M |
| 6 | Nextech Invest, Ltd. | 7.60M | $739.21M |
| 7 | Paradigm Biocapital Advisors LP | 6.66M | $647.27M |
| 8 | Wellington Management Group LLP | 6.03M | $586.21M |
| 9 | Adage Capital Partners Gp, L.L.C. | 5.48M | $532.50M |
| 10 | State Street Corp | 4.40M | $428.16M |